nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—DHFR—Methotrexate—muscle cancer	0.962	1	CbGbCtD
Trimetrexate—Hepatotoxicity—Dactinomycin—muscle cancer	0.00171	0.0549	CcSEcCtD
Trimetrexate—Hypocalcaemia—Dactinomycin—muscle cancer	0.00144	0.0463	CcSEcCtD
Trimetrexate—DHFR—embryo—muscle cancer	0.00129	0.194	CbGeAlD
Trimetrexate—Hepatotoxicity—Etoposide—muscle cancer	0.00124	0.0397	CcSEcCtD
Trimetrexate—DHFR—renal system—muscle cancer	0.000974	0.147	CbGeAlD
Trimetrexate—Phosphatase alkaline increased—Etoposide—muscle cancer	0.000954	0.0307	CcSEcCtD
Trimetrexate—DHFR—cardiac atrium—muscle cancer	0.000872	0.132	CbGeAlD
Trimetrexate—Aspartate aminotransferase increased—Dactinomycin—muscle cancer	0.000862	0.0277	CcSEcCtD
Trimetrexate—Hyponatraemia—Vincristine—muscle cancer	0.000859	0.0276	CcSEcCtD
Trimetrexate—Serum creatinine increased—Doxorubicin—muscle cancer	0.000805	0.0259	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Etoposide—muscle cancer	0.000796	0.0256	CcSEcCtD
Trimetrexate—Neutropenia—Dactinomycin—muscle cancer	0.000774	0.0249	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Vincristine—muscle cancer	0.00077	0.0247	CcSEcCtD
Trimetrexate—DHFR—tendon—muscle cancer	0.00076	0.115	CbGeAlD
Trimetrexate—Hepatotoxicity—Methotrexate—muscle cancer	0.00074	0.0238	CcSEcCtD
Trimetrexate—DHFR—bone marrow—muscle cancer	0.000736	0.111	CbGeAlD
Trimetrexate—DHFR—vagina—muscle cancer	0.000705	0.107	CbGeAlD
Trimetrexate—Neutropenia—Vincristine—muscle cancer	0.000691	0.0222	CcSEcCtD
Trimetrexate—DHFR—head—muscle cancer	0.000652	0.0985	CbGeAlD
Trimetrexate—DHFR—testis—muscle cancer	0.000629	0.0951	CbGeAlD
Trimetrexate—Alanine aminotransferase increased—Etoposide—muscle cancer	0.000611	0.0196	CcSEcCtD
Trimetrexate—Neutropenia—Etoposide—muscle cancer	0.00056	0.018	CcSEcCtD
Trimetrexate—Hypocalcaemia—Doxorubicin—muscle cancer	0.000541	0.0174	CcSEcCtD
Trimetrexate—Anaemia—Dactinomycin—muscle cancer	0.000533	0.0171	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Doxorubicin—muscle cancer	0.000523	0.0168	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Doxorubicin—muscle cancer	0.000495	0.0159	CcSEcCtD
Trimetrexate—Anaemia—Vincristine—muscle cancer	0.000476	0.0153	CcSEcCtD
Trimetrexate—Thrombocytopenia—Dactinomycin—muscle cancer	0.000461	0.0148	CcSEcCtD
Trimetrexate—Convulsion—Vincristine—muscle cancer	0.000446	0.0143	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.000413	0.0133	CcSEcCtD
Trimetrexate—Thrombocytopenia—Vincristine—muscle cancer	0.000412	0.0132	CcSEcCtD
Trimetrexate—Fatigue—Dactinomycin—muscle cancer	0.000406	0.013	CcSEcCtD
Trimetrexate—Feeling abnormal—Dactinomycin—muscle cancer	0.000388	0.0125	CcSEcCtD
Trimetrexate—Anaemia—Etoposide—muscle cancer	0.000386	0.0124	CcSEcCtD
Trimetrexate—Body temperature increased—Dactinomycin—muscle cancer	0.000372	0.012	CcSEcCtD
Trimetrexate—Fatigue—Vincristine—muscle cancer	0.000362	0.0116	CcSEcCtD
Trimetrexate—Convulsion—Etoposide—muscle cancer	0.000361	0.0116	CcSEcCtD
Trimetrexate—Hyponatraemia—Doxorubicin—muscle cancer	0.000361	0.0116	CcSEcCtD
Trimetrexate—Confusional state—Etoposide—muscle cancer	0.000343	0.011	CcSEcCtD
Trimetrexate—Asthenia—Dactinomycin—muscle cancer	0.000338	0.0108	CcSEcCtD
Trimetrexate—Blood creatinine increased—Doxorubicin—muscle cancer	0.000337	0.0108	CcSEcCtD
Trimetrexate—Neutropenia—Methotrexate—muscle cancer	0.000335	0.0108	CcSEcCtD
Trimetrexate—Thrombocytopenia—Etoposide—muscle cancer	0.000333	0.0107	CcSEcCtD
Trimetrexate—Body temperature increased—Vincristine—muscle cancer	0.000332	0.0107	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000324	0.0104	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000317	0.0102	CcSEcCtD
Trimetrexate—Asthenia—Vincristine—muscle cancer	0.000302	0.00969	CcSEcCtD
Trimetrexate—Vomiting—Dactinomycin—muscle cancer	0.000299	0.00961	CcSEcCtD
Trimetrexate—Rash—Dactinomycin—muscle cancer	0.000297	0.00953	CcSEcCtD
Trimetrexate—Fatigue—Etoposide—muscle cancer	0.000294	0.00943	CcSEcCtD
Trimetrexate—Neutropenia—Doxorubicin—muscle cancer	0.00029	0.00933	CcSEcCtD
Trimetrexate—Feeling abnormal—Etoposide—muscle cancer	0.000281	0.00902	CcSEcCtD
Trimetrexate—Nausea—Dactinomycin—muscle cancer	0.000279	0.00898	CcSEcCtD
Trimetrexate—Body temperature increased—Etoposide—muscle cancer	0.000269	0.00865	CcSEcCtD
Trimetrexate—Vomiting—Vincristine—muscle cancer	0.000267	0.00859	CcSEcCtD
Trimetrexate—Rash—Vincristine—muscle cancer	0.000265	0.00852	CcSEcCtD
Trimetrexate—Dermatitis—Vincristine—muscle cancer	0.000265	0.00851	CcSEcCtD
Trimetrexate—Nausea—Vincristine—muscle cancer	0.00025	0.00802	CcSEcCtD
Trimetrexate—Asthenia—Etoposide—muscle cancer	0.000244	0.00785	CcSEcCtD
Trimetrexate—Pruritus—Etoposide—muscle cancer	0.000241	0.00774	CcSEcCtD
Trimetrexate—Anaemia—Methotrexate—muscle cancer	0.000231	0.00742	CcSEcCtD
Trimetrexate—Convulsion—Methotrexate—muscle cancer	0.000217	0.00696	CcSEcCtD
Trimetrexate—Vomiting—Etoposide—muscle cancer	0.000216	0.00696	CcSEcCtD
Trimetrexate—Rash—Etoposide—muscle cancer	0.000215	0.0069	CcSEcCtD
Trimetrexate—Dermatitis—Etoposide—muscle cancer	0.000214	0.00689	CcSEcCtD
Trimetrexate—Confusional state—Methotrexate—muscle cancer	0.000206	0.00661	CcSEcCtD
Trimetrexate—Nausea—Etoposide—muscle cancer	0.000202	0.0065	CcSEcCtD
Trimetrexate—Anaemia—Doxorubicin—muscle cancer	0.0002	0.00643	CcSEcCtD
Trimetrexate—Thrombocytopenia—Methotrexate—muscle cancer	0.0002	0.00642	CcSEcCtD
Trimetrexate—Convulsion—Doxorubicin—muscle cancer	0.000187	0.00603	CcSEcCtD
Trimetrexate—Confusional state—Doxorubicin—muscle cancer	0.000178	0.00572	CcSEcCtD
Trimetrexate—Fatigue—Methotrexate—muscle cancer	0.000176	0.00565	CcSEcCtD
Trimetrexate—Thrombocytopenia—Doxorubicin—muscle cancer	0.000173	0.00556	CcSEcCtD
Trimetrexate—Feeling abnormal—Methotrexate—muscle cancer	0.000168	0.0054	CcSEcCtD
Trimetrexate—Body temperature increased—Methotrexate—muscle cancer	0.000161	0.00518	CcSEcCtD
Trimetrexate—Fatigue—Doxorubicin—muscle cancer	0.000152	0.00489	CcSEcCtD
Trimetrexate—Asthenia—Methotrexate—muscle cancer	0.000146	0.0047	CcSEcCtD
Trimetrexate—Feeling abnormal—Doxorubicin—muscle cancer	0.000146	0.00468	CcSEcCtD
Trimetrexate—Pruritus—Methotrexate—muscle cancer	0.000144	0.00464	CcSEcCtD
Trimetrexate—Body temperature increased—Doxorubicin—muscle cancer	0.00014	0.00449	CcSEcCtD
Trimetrexate—Vomiting—Methotrexate—muscle cancer	0.00013	0.00417	CcSEcCtD
Trimetrexate—Rash—Methotrexate—muscle cancer	0.000129	0.00413	CcSEcCtD
Trimetrexate—Dermatitis—Methotrexate—muscle cancer	0.000128	0.00413	CcSEcCtD
Trimetrexate—Asthenia—Doxorubicin—muscle cancer	0.000127	0.00407	CcSEcCtD
Trimetrexate—Pruritus—Doxorubicin—muscle cancer	0.000125	0.00402	CcSEcCtD
Trimetrexate—Nausea—Methotrexate—muscle cancer	0.000121	0.00389	CcSEcCtD
Trimetrexate—Vomiting—Doxorubicin—muscle cancer	0.000112	0.00361	CcSEcCtD
Trimetrexate—Rash—Doxorubicin—muscle cancer	0.000111	0.00358	CcSEcCtD
Trimetrexate—Dermatitis—Doxorubicin—muscle cancer	0.000111	0.00358	CcSEcCtD
Trimetrexate—Nausea—Doxorubicin—muscle cancer	0.000105	0.00337	CcSEcCtD
